全球细胞分析市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球细胞分析市场 – 行业趋势和 2030 年预测

  • Healthcare
  • Upcoming Report
  • Jan 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Cell Analysis Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 18.41 Billion
Diagram Market Size (Forecast Year)
USD 33.82 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>全球细胞分析市场,按产品(流式细胞术产品、QPCR 产品、细胞微阵列、显微镜、分光光度计、细胞计数器、高内涵筛选系统、其他产品)、流程(细胞识别、细胞活力、细胞信号通路/信号转导、细胞增殖、细胞计数和质量控制、细胞相互作用、细胞结构研究、目标识别和验证、单细胞分析)、最终用户(制药和生物技术公司和合同研究组织 (CROS)、医院和诊断实验室、研究机构、细胞培养物收集库、其他最终用户)– 行业趋势和预测到 2030 年。

细胞分析市场

细胞分析市场分析和规模

根据美国癌症协会的数据,癌症是美国第二大死亡原因,仅次于心脏病。根据癌症统计数据,预计 2022 年美国将新增 190 万例癌症病例。因此,癌症发病率的上升以及该领域永无止境的研究和开发预计将对行业增长产生积极影响。

Data Bridge Market Research 分析,细胞分析市场在 2022 年的规模为 184.1 亿美元,预计到 2030 年将达到 338.2 亿美元,在 2023 年至 2030 年的预测期内的复合年增长率为 7.9%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

细胞分析市场范围和细分  

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

产品(流式细胞仪产品、QPCR 产品、细胞微阵列、显微镜、分光光度计、细胞计数器、高内涵筛选系统、其他产品)、流程(细胞识别、细胞活力、细胞信号通路/信号转导、细胞增殖、细胞计数和质量控制、细胞相互作用、细胞结构研究、靶标识别和验证、单细胞分析)、最终用户(制药和生物技术公司和合同研究组织 (CROS)、医院和诊断实验室、研究机构、细胞培养物保藏库、其他最终用户)

覆盖国家

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), General Electric (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc (U.S.), Olympus Corporation (Japan), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Tecan Trading AG (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), BioStatus Limited (U.K.), NanoCellect Biomedical (U.S.)

Market Opportunities

  • Technological advancements in cell analysis

Market Definition

Cell analysis is an umbrella term for a wide range of technologies used to study a cell's genetic and phenotypical characteristics. Its goal is to gain insights into the mechanisms of cellular functionality, which necessitates an understanding of cellular components such as DNA, RNA, protein content, and cellular metabolites. Cell analysis is commonly used to understand population heterogeneity, identify minority subpopulations of interest, and discover unique characteristics of individual cells. It also helps with gene and protein identification, epigenomics, and understanding the factors that govern cell health, proliferation, and death.

Cell Analysis Market Dynamics

Drivers

  • Growing demand for analytical tools

The increasing demand for analytical tools for innovative research and subsequent funding has resulted in the introduction of high-throughput equipment. Multiple innovations have led to this equipment incorporating features such as automation, high sensitivity, and accuracy, all of which aid in the analysis of scarce samples. For instance, Deepcell Inc., a U.S.-based company, received USD 73 million in funding in March 2022 to accelerate and commercialize its AI-powered single cell analysis platform. As a result, key players are significantly investing in developing solutions, resulting in a lucrative revenue generation opportunity in the coming years.

Opportunities

  • Technological advancements in cell analysis

The rising prevalence of chronic diseases and the development of advanced cancer therapies are driving technological advancements in cell analysis. For instance, Fluidigm Corporation, based in the United States, announced the launch of a REAP-seq (RNA expression and protein sequencing) platform that will aid researchers in understanding the mechanisms of cancer progression and immune response.

Restraints/Challenges

  • High cost associated with instruments

Large costs associated with the use of instruments and complex and time-consuming guidelines will be some of the constraints that will hamper the cell analysis during the forecast period. The greatest challenge to the market's growth will be a lack of skilled professionals.

This cell analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cell analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2022, Lifebit, a big data company based in the United Kingdom, announced a partnership with Boehringer Ingelheim. The collaboration will use Lifebit's Cloud OS, the first federated genomics platform, to build a data analytics infrastructure for Boehringer. This infrastructure will collect disease insights from biobanks in order to develop medicines.
  • In 2021, SeqWell Inc. announced the release of the plexWell Single Cell Rapid Kit. The kit can be used for single-cell RNA sequencing as well as simplified NGS library preparation.

Global Cell Analysis Market Scope

The cell analysis market is segmented on the basis of product, process and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Flow Cytometry Products
  • Reagents and Consumables
  •  Instruments
  •  Accessories
  •  Software
  • Qpcr Products
  • Reagents and Consumables
  •  Instruments
  • Cell Microarrays
  • Consumables
  • Instruments
  • Microscopes
  • Electron Microscopes
  • Inverted Microscopes
  •  Stereo Microscopes
  •  Fluorescence and Confocal Microscopes
  •  Phase-Contrast Microscopes
  •  Near-Field Scanning Optical Microscopes
  • Other Microscopes
  • Spectrophotometers
  • Single-Mode Readers
  • Multi-Mode Readers
  • Cell Counters
  • Automated Cell Counters
  •  Hemocytometers
  • Manual Cell Counters
  • High-Content Screening Systems
  • Other Products

 Process

  • Cell Identification
  • Cell Viability
  • Cell Signalling Pathway/Signal Transduction
  • Cell Proliferation
  • Cell Counting and Quality Control
  • Cell Interaction
  • Cell Structure Study
  • Target Identification and Validation
  • Single-Cell Analysis

 End User

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROS)
  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Cell Culture Collection Repositories
  • Other End Users

Cell Analysis Market Regional Analysis/Insights

对细胞分析市场进行了分析,并按国家、产品、流程和最终用户提供了市场规模洞察和趋势,如上所述。

细胞分析市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于商业环境的普遍性、政府对药物研发的投资增加以及该地区研究活动数量的增加,北美在细胞分析市场中占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

细胞分析市场还为您提供每个国家/地区资本设备医疗支出增长、细胞分析市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对细胞分析市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和细胞分析市场份额分析

细胞分析市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对细胞分析市场的关注有关。

细胞分析市场的一些主要参与者包括:

  • 丹纳赫(美国)
  • 赛默飞世尔科技公司(美国)
  • BD(美国)
  • 通用电气(美国)
  • 默克集团(德国)
  • 安捷伦科技公司(美国)
  • 奥林巴斯株式会社(日本)
  • Promega 公司 (美国)
  • PerkinElmer Inc.(美国)
  • Tecan Trading AG(瑞士)
  • Miltenyi Biotec(德国)
  • 卡尔蔡司公司(德国)
  • Bio-Rad Laboratories, Inc.(美国)
  • Sysmex 公司 (日本)
  • BioStatus Limited(英国)
  • NanoCellect Biomedical(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Cell Analysis Market is projected to grow at a CAGR of 7.9% during the forecast period by 2030.
The future market value of the Cell Analysis Market is expected to reach USD 33.82 billion by 2030.
The major players in the Cell Analysis Market are Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), General Electric (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc (U.S.), Olympus Corporation (Japan), Promega Corporation (U.S.), etc.
The countries covered in the Cell Analysis Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.